Skandinaviska Enskilda Banken (SEB)
UTHR icon

Skandinaviska Enskilda Banken (SEB)’s United Therapeutics UTHR Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,946
Closed -$9.23M – 679
2025
Q4 		$9.23M Sell
18,946
-36
-0.2% -$16.8K 0.04% 295
2025
Q3 		$7.95M Sell
18,982
-70,978
-79% -$23.9M 0.03% 323
2025
Q2 		$25.9M Sell
89,960
-10,894
-11% -$3.26M 0.11% 150
2025
Q1 		$31.1M Buy
100,854
+16,849
+20% +$5.77M 0.15% 122
2024
Q4 		$30M Sell
84,005
-10,768
-11% -$3.96M 0.14% 131
2024
Q3 		$34M Buy
94,773
+7,403
+8% +$2.5M 0.16% 120
2024
Q2 		$27.8M Buy
87,370
+28,192
+48% +$7.46M 0.13% 129
2024
Q1 		$13.6M Buy
59,178
+1,484
+3% +$335K 0.07% 227
2023
Q4 		$12.7M Sell
57,694
-1,262
-2% -$291K 0.07% 226
2023
Q3 		$13.3M Sell
58,956
-1,144
-2% -$263K 0.09% 206
2023
Q2 		$13.3M Buy
60,100
+52,028
+645% +$11.5M 0.09% 222
2023
Q1 		$1.81M Buy
+8,072
New +$1.99M 0.01% 571
2022
Q4 		– Sell
-200
Closed -$42K – 914
2022
Q3 		$42K Sell
200
-500
-71% -$112K ﹤0.01% 863
2022
Q2 		$165K Hold
700
– – ﹤0.01% 886
2022
Q1 		$126K Buy
+700
New +$133K ﹤0.01% 919
2021
Q3 		– Sell
-2,600
Closed -$466K – 1099
2021
Q2 		$466K Hold
2,600
– – ﹤0.01% 889
2021
Q1 		$435K Sell
2,600
-16,078
-86% -$2.68M ﹤0.01% 948
2020
Q4 		$2.83M Sell
18,678
-3,900
-17% -$512K 0.02% 521
2020
Q3 		$2.28M Sell
22,578
-700
-3% -$76.8K 0.02% 534
2020
Q2 		$2.82M Buy
23,278
+900
+4% +$101K 0.02% 471
2020
Q1 		$2.12M Sell
22,378
-7,400
-25% -$703K 0.02% 458
2019
Q4 		$2.62M Sell
29,778
-700
-2% -$61.6K 0.02% 483
2019
Q3 		$2.43M Sell
30,478
-2,700
-8% -$217K 0.02% 488
2019
Q2 		$2.59M Sell
33,178
-225,345
-87% -$21.1M 0.02% 442
2019
Q1 		$30.3M Sell
258,523
-73,600
-22% -$8.58M 0.28% 80
2018
Q4 		$36.2M Sell
332,123
-135,200
-29% -$15.7M 0.32% 66
2018
Q3 		$59.8M Sell
467,323
-328,803
-41% -$40.7M 0.45% 53
2018
Q2 		$90.1M Sell
796,126
-44,497
-5% -$4.89M 0.77% 33
2018
Q1 		$94.5M Sell
840,623
-202,700
-19% -$25.8M 0.91% 26
2017
Q4 		$154M Buy
1,043,323
+370,500
+55% +$47.1M 1.33% 15
2017
Q3 		$78.8M Sell
672,823
-63,200
-9% -$8.07M 0.71% 30
2017
Q2 		$95.5M Buy
736,023
+74,300
+11% +$9.27M 0.92% 23
2017
Q1 		$89.6M Buy
661,723
+6,900
+1% +$1.05M 0.9% 25
2016
Q4 		$93.9M Sell
654,823
-22,255
-3% -$2.84M 1.13% 24
2016
Q3 		$79.9M Buy
677,078
+3,700
+0.5% +$445K 0.87% 25
2016
Q2 		$71.3M Sell
673,378
-26,300
-4% -$2.93M 0.8% 26
2016
Q1 		$78M Buy
699,678
+46,200
+7% +$5.85M 0.87% 26
2015
Q4 		$102M Buy
+653,478
New +$95.1M 1.33% 21

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s UTHR Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 18,946 shares — an estimated $9.23M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in UTHR in Q4 2015 and held it in 38 quarters. The position peaked at $154M in Q4 2017. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 18,946 United Therapeutics shares in Q1 2026, an estimated $9.23M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in United Therapeutics in Q4 2015 and held it in 38 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s United Therapeutics position peaked at $154M in Q4 2017.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.